Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing Allophenylnorstatine
- 24 April 1999
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (10) , 1789-1802
- https://doi.org/10.1021/jm980637h
Abstract
We designed and synthesized a new class of peptidomimetic human immunodeficiency virus (HIV) protease inhibitors containing a unique unnatural amino acid, allophenylnorstatine [Apns; (2S,3S)-3-amino-2-hydroxy-4-phenylbutyric acid], with a hydroxymethylcarbonyl (HMC) isostere as the active moiety. A systematic evaluation of structure−activity relationships for HIV protease inhibition, anti-HIV activities, and pharmacokinetic profiles has led to the delineation of a set of structural charateristics that appear to afford an orally available HIV protease inhibitor. Optimum structures, exemplified by 21f (JE-2147), incorporated 3-hydroxy-2-methylbenzoyl groups as the P2 ligand, (R)-5,5-dimethyl-1,3-thiazolidine-4-carbonyl (Dmt) residue at the P1‘ site, and 2-methylbenzylcarboxamide group as the P2‘ ligand. The present study demonstrated that JE-2147 has potent antiviral activities in vitro and exhibits good oral bioavailability and plasma pharmacokinetic profiles in two species of laboratory animals.Keywords
This publication has 14 references indexed in Scilit:
- (Hydroxyethyl) sulfonamide HIV-1 Protease inhibitors: Identification of the 2-methylbenzoyl moiety at P-2Bioorganic & Medicinal Chemistry Letters, 1996
- Current Status of the Development of HIV Protease Inhibitors and Their Clinical PotentialClinical Immunotherapeutics, 1995
- Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostereStructure, 1995
- Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diolJournal of Medicinal Chemistry, 1993
- Development of selective tight-binding inhibitors of leukotriene A4 hydrolaseJournal of Medicinal Chemistry, 1993
- Kynostatin (KNI-227 and -272, highly potent anti-HIV agents: conformationally constrained tripeptide inhibitors of HIV protease containing allophenylnorstatine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 ProteaseScience, 1990
- New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral ActivityJNCI Journal of the National Cancer Institute, 1989
- Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virusCell, 1988
- Synthesis and structure-activity relations of bestatin analogs, inhibitors of aminopeptidase BJournal of Medicinal Chemistry, 1977